Genomic Evaluation of Malignant Pediatric Cortical Tumors

2nd Annual CBTTC Investigator Meeting, The Westin New Orleans Canal Place, New Orleans

May 25, 2016
Sarah Leary, MD, Seattle Children’s Hospital


This research focuses on identifying the genomic alterations and tumor subtypes within a large cohort of well characterized supratentorial malignant pediatric brain tumors. Evaluating the association between genetically determined subtypes and standard clinical factors such as histology, location, metastatic status, and survival will provide comprehensive understanding for clinical impact. Additionally, this research will help prioritize molecular alterations which warrant further study as potential biomarkers.